AR216916A1 - Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales - Google Patents

Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales

Info

Publication number
AR216916A1
AR216916A1 AR268053A AR26805377A AR216916A1 AR 216916 A1 AR216916 A1 AR 216916A1 AR 268053 A AR268053 A AR 268053A AR 26805377 A AR26805377 A AR 26805377A AR 216916 A1 AR216916 A1 AR 216916A1
Authority
AR
Argentina
Prior art keywords
pirido
fenil
triazol
diazepinas
alquil
Prior art date
Application number
AR268053A
Other languages
English (en)
Original Assignee
Degussa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Degussa filed Critical Degussa
Application granted granted Critical
Publication of AR216916A1 publication Critical patent/AR216916A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/64One oxygen atom attached in position 2 or 6
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/70Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
AR268053A 1975-11-04 1977-06-14 Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales AR216916A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT837275A AT350056B (de) 1975-11-04 1975-11-04 Verfahren zur herstellung von neuen pyrido- (2,3-f)-(1,4)-diazepinen, deren optischen isomeren und salzen

Publications (1)

Publication Number Publication Date
AR216916A1 true AR216916A1 (es) 1980-02-15

Family

ID=3604891

Family Applications (3)

Application Number Title Priority Date Filing Date
AR265336A AR217814A1 (es) 1975-11-04 1976-11-03 Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas
AR268053A AR216916A1 (es) 1975-11-04 1977-06-14 Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales
AR268052A AR216915A1 (es) 1975-11-04 1977-06-14 Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR265336A AR217814A1 (es) 1975-11-04 1976-11-03 Procedimiento para la preparacion de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)(c1,4)-diazepinas

Family Applications After (1)

Application Number Title Priority Date Filing Date
AR268052A AR216915A1 (es) 1975-11-04 1977-06-14 Procedimiento para la preparacion de 1-ceto-6(2-halofenil)-8-halo-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas-2-sustituidas

Country Status (30)

Country Link
US (1) US4110455A (es)
JP (1) JPS5831351B2 (es)
AR (3) AR217814A1 (es)
AT (1) AT350056B (es)
AU (1) AU504228B2 (es)
BE (1) BE847952A (es)
CA (1) CA1076111A (es)
CH (1) CH630920A5 (es)
CS (1) CS191181B2 (es)
DD (1) DD128178A5 (es)
DE (1) DE2649116A1 (es)
DK (1) DK142324B (es)
EG (1) EG12280A (es)
ES (2) ES452969A1 (es)
FI (1) FI62088C (es)
FR (1) FR2330404A1 (es)
GB (1) GB1562800A (es)
HU (1) HU177422B (es)
IL (1) IL50816A (es)
IN (1) IN144289B (es)
MX (1) MX4284E (es)
NL (1) NL7612187A (es)
NO (1) NO146470C (es)
PL (2) PL118308B1 (es)
PT (1) PT65787B (es)
RO (2) RO77294A (es)
SE (1) SE7612260L (es)
SU (2) SU667137A3 (es)
YU (1) YU269176A (es)
ZA (1) ZA766620B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1185601A (en) * 1981-02-27 1985-04-16 Walter Hunkeler Imidazodiazepines
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
US4798896A (en) * 1988-01-19 1989-01-17 American Home Products Corporation Antipsychotic gamma-carboline N-oxides
WO2011123678A2 (en) * 2010-03-31 2011-10-06 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
WO2012151512A2 (en) 2011-05-04 2012-11-08 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
WO2013184878A1 (en) 2012-06-06 2013-12-12 Constellation Pharmaceuticals, Inc. Benzo [b] isoxazoloazepine bromodomain inhibitors and uses thereof
HUE043441T2 (hu) 2014-06-20 2019-08-28 Constellation Pharmaceuticals Inc 2-((4S)-6-(4-klórfenil)-l-metil-4H-benzo[c]izoxazolo[4,5-e]azepin-4-il)acetamid kristályos formái

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT327917B (de) * 1973-04-12 1976-02-25 Degussa Verfahren zur herstellung von neuen 5-aryl-pyrido- (b-6,7) -1,4-diazepinen und deren salzen
US4039551A (en) * 1976-03-15 1977-08-02 The Upjohn Company 1-[(Hydroxyamino)methyl]-6-aryl-4H-s-triazolo[4,3-a][1,4]benzodiazepines

Also Published As

Publication number Publication date
CH630920A5 (de) 1982-07-15
SU667137A3 (ru) 1979-06-05
JPS5831351B2 (ja) 1983-07-05
ATA837275A (de) 1978-10-15
ZA766620B (en) 1977-12-28
MX4284E (es) 1982-03-12
DK142324C (es) 1981-03-02
FI62088B (fi) 1982-07-30
CS191181B2 (en) 1979-06-29
YU269176A (en) 1983-02-28
PL113803B1 (en) 1981-01-31
AU1931176A (en) 1978-05-11
CA1076111A (en) 1980-04-22
FI763158A (es) 1977-05-05
DK142324B (da) 1980-10-13
DE2649116A1 (de) 1977-05-18
GB1562800A (en) 1980-03-19
ES452969A1 (es) 1977-11-16
RO77294A (ro) 1982-09-09
NO146470B (no) 1982-06-28
PL118308B1 (en) 1981-09-30
FR2330404A1 (fr) 1977-06-03
RO70245A (ro) 1981-06-30
SE7612260L (sv) 1977-05-05
PT65787B (de) 1978-05-10
US4110455A (en) 1978-08-29
HU177422B (en) 1981-10-28
FR2330404B1 (es) 1979-07-20
BE847952A (fr) 1977-05-03
AR217814A1 (es) 1980-04-30
FI62088C (fi) 1982-11-10
NO763739L (es) 1977-05-05
NO146470C (no) 1982-10-06
PT65787A (de) 1976-12-01
DD128178A5 (de) 1977-11-02
IL50816A0 (en) 1977-01-31
AT350056B (de) 1979-05-10
EG12280A (en) 1978-12-31
SU676165A3 (ru) 1979-07-25
AU504228B2 (en) 1979-10-04
NL7612187A (nl) 1977-05-06
ES452971A1 (es) 1978-10-16
JPS5259194A (en) 1977-05-16
IL50816A (en) 1980-09-16
AR216915A1 (es) 1980-02-15
IN144289B (es) 1978-04-22
PL193439A1 (pl) 1979-07-16
DK497076A (es) 1977-05-05

Similar Documents

Publication Publication Date Title
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR220686A1 (es) Procedimiento para obtener derivados de 2 amino-2-desoxi-3-o-(propilcarbamoilmetil)-carbamoilmetil-glucopiranosa y sus sales
MX4717E (es) Procedimiento para la preparacion de derivados de pirrolidina
AR224495A1 (es) Procedimiento para la preparacion de derivados de 1-fenil-7,8-dihidroxi o 7,8-dialcanoiloxi-1,3,4,5-tetrahidro-1h-3-benzazepina y sus sales
MX4488E (es) Procedimiento para la preparacion de derivados de quinazolona
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
AR222290A1 (es) Procedimiento para obtener derivados de 5-het'-metil-2-het-metiltio-etilamino o 2-het-butilamino pirimidin-4-ona
AR228949A1 (es) Procedimiento para la preparacion de nuevos derivados de pirido(1,2-a)pirimidina y sus sales
AR213736A1 (es) Procedimiento para la preparacion de(2-(3 o 4)-alcoxi-2-piridil-(metiltio o etil)etil)-(ciano-guanidina o alquilaminonitroetileno)
AR211887A1 (es) Procedimiento para la preparacion de derivados de endolizina
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR216916A1 (es) Procedimiento para la elaboracion de nuevas 1-ceto-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o de 6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-mercapto alquil(c1-c4)-6-fenil-s-triazol-(4,3-a)-pirido-(2,3-f)o 1-alcoxi-(c1-c4)-6-fenil-s-triazol(4,3-a)-pirido-(2,3-f)-(1,4)-diazepinas y sus sales
MX3636E (es) Procedimiento para la preparacion de propargil-2-fenilamino-imidazolinas-(2)
AR231539A1 (es) Procedimiento para la elaboracion de nuevos derivados de la curamina o del 4n-1-benzopirano y sus sales
MX4796E (es) Procedimiento para la preparacion de derivados de 2-iminotiazolina
AR213184A1 (es) Procedimiento para preparar derivados de 1,4-etan-6-oxo-perhidroquinoleina y sus sales
AR225889A1 (es) Procedimiento para la elaboracion de acidos heterociclilcarboxilicos acilados
AR215851A1 (es) Procedimiento para la preparacion de 12,13-desepoxi-12,13-dehidrorosaramicina y derivados de la misma
AR208361A1 (es) Procedimiento para la preparacion de derivados l-piroglutamil-l-histidil-3-alquil-prolinamida
AR217664A1 (es) Procedimiento para la preparacion de derivados de oleandomicina
MX143905A (es) Procedimiento para la preparacion de sales de 4-amino bencendiazonio
AR211546A1 (es) Procedimiento para la produccion de nuevas 2-fenilimino-tiazolinas substituidas y sus sales
MX3845E (es) Procedimiento para la preparacion de sulfoximidas substituidas y sus sales
MX4485E (es) Procedimiento para la preparacion de 2,4-diamino-5-bencil-pirimidinas y sus sales
MX3539E (es) Procedimiento para la paeparacion de 1-metil-2-(fenil-oximetil)-5-nitro-imidazoles